Skip to main content
Premium Trial:

Request an Annual Quote

Luminex: Dijuana Lewis

Luminex has elected Dijuana Lewis as an independent director to its board of directors, to the board's compensation and nominating committee, and to its corporate governance committee.

In a filing with the US Securities and Exchange Commission, Luminex reported that Lewis has served on various nonprofit and advisory boards and has consulted on healthcare related matters since her retirement from Aetna in April 2016.

She served Aetna as executive vice president, consumer products and enterprise marketing from October 2013 to April 2016. Prior to that, she served as senior vice president, health and wellness for Walmart Stores from March 2011 to October 2013. Further, Lewis previously served in a number of executive level positions of increasing responsibility with Anthem/Wellpoint from August 1994 to January 2011, including as the executive vice president and chief executive officer of its comprehensive health solutions division from October 2007 to January 2011.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.